Who owns HALOZYME THERAPEUTICS INC NOTE 1.000 8/1?
- CUSIP Number: 40637haf6
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics Inc Note 1.000 8/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics Inc Note 1.000 8/1 stock
Who bought or sold HALOZYME THERAPEUTICS INC NOTE 1.000 8/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 66M | $97M | 163% | Jun 2026 |
|
| LMR Partners | 45M | $66M | 0% | Jun 2026 |
|
| Point72 Asset Management | 41M | $61M | -13% | Jun 2026 |
|
| Tenor Capital Management | 38M | $56M | -31% | Jun 2026 |
|
| Alberta Investment Management Corporation | 35M | $51M | 0% | Jun 2026 |
|
| Lombard Odier Asset Management | 20M | $29M | 100% | Jun 2026 |
|
| Millennium Management | 19M | $28M | -35% | Jun 2026 |
|
| Lazard Asset Management | 18M | $257k | 9% | Jun 2026 |
|
| Absolute Investment Advisers | 14M | $20M | 0% | Jun 2026 |
|
| Linden Advisors | 13M | $19M | 0% | Jun 2026 |
|
| Calamos Advisors | 12M | $17M | 1% | Jun 2026 |
|
| BlackRock | 10M | $15M | 33% | Jun 2026 |
|
| Advent Capital Management | 9.1M | $13M | 16% | Jun 2026 |
|
| State Street Corporation | 9.0M | $12M | -6% | Mar 2026 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 8.1M | $12M | 0% | Jun 2026 |
|
| Ofi Invest Asset Management | 6.8M | $8.7M | 0% | Jun 2026 |
|
| FMR | 6.8M | $9.9M | 1% | Jun 2026 |
|
| Jpmorgan Chase & Co | 6.4M | $9.3M | 100% | Jun 2026 |
|
| SSI Investment Management | 6.1M | $8.9M | 0% | Jun 2026 |
|
| Bank Of Montreal | 6.0M | $7.7M | 100% | Mar 2026 |
|
| Wells Fargo & Company | 5.8M | $8.4M | -6% | Jun 2026 |
|
| Lord, Abbett & Co | 5.6M | $8.1M | 100% | Jun 2026 |
|
| La Banque Postale Asset Management SA | 5.0M | $7.3M | 100% | Jun 2026 |
|
| Union Bancaire Privee, UBP SA | 4.6M | $5.8M | 10% | Jun 2026 |
|
| Ing Investment Management | 4.0M | $5.8M | -33% | Jun 2026 |
|
| State of Wisconsin Investment Board | 4.0M | $5.8M | 33% | Jun 2026 |
|
| Warberg Asset Management | 3.5M | $5.1M | -42% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 3.0M | $4.4M | 100% | Jun 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 2.7M | $3.9M | 3% | Jun 2026 |
|
| Morgan Stanley | 2.4M | $3.1M | -75% | Mar 2026 |
|
| Colony | 2.2M | $3.2M | -5% | Jun 2026 |
|
| Capital World Investors | 2.2M | $2.8M | 0% | Mar 2026 |
|
| Nykredit A/S | 1.5M | $2.2M | 100% | Jun 2026 |
|
| Barclays | 1.2M | $1.7M | 100% | Jun 2026 |
|
| Balyasny Asset Management | 1.0M | $1.5M | -94% | Jun 2026 |
|
| Agf Management | 1.0M | $1.5M | -33% | Jun 2026 |
|
| Zurcher Kantonalbank | 500k | $734k | 0% | Jun 2026 |
|
| Bank of New York Mellon | 410k | $601k | -33% | Jun 2026 |
|
| Man Group | 370k | $541k | 0% | Jun 2026 |
|
| Royal Bank of Canada | 366k | $536k | 0% | Jun 2026 |
|
| Central Pacific Bank - Trust Division | 317k | $463k | 0% | Jun 2026 |
|
| Russell Investments | 232k | $341k | 0% | Jun 2026 |
|
| RWC Asset Management | 201k | $295k | 100% | Jun 2026 |
|
| Virtus Fixed Income Advisers | 152k | $222k | 100% | Jun 2026 |
|
| Virtus ETF Advisers | 35k | $51k | 0% | Jun 2026 |
|
| Franklin Resources | 10k | $15k | -100% | Jun 2026 |
|
| Steward Partners Investment Advisory | 6.0k | $8.8k | 0% | Jun 2026 |
|
| Us Bancorp | 5.0k | $7.3k | 0% | Jun 2026 |
|
| Alken Asset Management | 2.1k | $3.1M | 5% | Jun 2026 |
|
| Boussard & Gavaudan Investment Management | 2.1k | $2.7M | 100% | Mar 2026 |
|
| UBS Group | 2.0k | $2.9k | 50% | Jun 2026 |
|
Who sold out of Halozyme Therapeutics Inc Note 1.000 8/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Invesco | Mar 2026 | 6.5M | $8.3M |
| Bank of America Corporation | Mar 2026 | 2.1M | $2.7M |
| Goldman Sachs Group | Mar 2026 | 900k | $1.2M |
| Dnca Finance | Mar 2026 | 630k | $812k |
| Jane Street | Mar 2026 | 118k | $153k |
| Ares Systematic Credit | Mar 2026 | 100k | $125k |
| Loomis, Sayles and | Mar 2026 | 5.2k | $335k |